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Studies using low-resolution methods to assess gene expression during preimplantation mouse development indicate that changes in gene
expression either precede or occur concomitantly with the major morphological transitions, that is, conversion of the oocyte to totipotent 2-
cell blastomeres, compaction, and blastocyst formation. Using microarrays, we characterized global changes in gene expression and used
Expression Analysis Systematic Explorer (EASE) to identify biological and molecular processes that accompany and likely underlie these
transitions. The analysis confirmed previously described processes or events, but more important, EASE revealed new insights. Response to
DNA damage and DNA repair genes are overrepresented in the oocyte compared to 1-cell through blastocyst stages and may reflect the
oocyte’s response to selective pressures to insure genomic integrity; fertilization results in changes in the transcript profile in the 1-cell
embryo that are far greater than previously recognized; and genome activation during 2-cell stage may not be as global and promiscuous as
previously proposed, but rather far more selective, with genes involved in transcription and RNA processing being preferentially expressed.
These results validate this hypothesis-generating approach by identifying genes involved in critical biological processes that can be the
subject of a more traditional hypothesis-driven approach.
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Mouse preimplantation development is characterized by
three major transitions, each of which entails pronounced
changes in the pattern of gene expression. The first transi-
tion is the maternal-to-zygotic transition (MZT) that serves
three functions. The first is to destroy oocyte-specific tran-
scripts (e.g., H1oo; Tanaka et al., 2001; and Msy2; Yu et al.,
2001). The second is to replace maternal transcripts that are
common to the oocyte and early embryo, for example, actin
(Davis et al., 1996) with zygotic transcripts. Although the
expression of these transcripts does not result in reprogram-
ming of gene expression in a classical sense, their expres-
sion is nonetheless essential for further development. The
MZT’s third function is to promote the dramatic reprogram-
ming in the pattern of gene expression that is coupled with0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.05.018
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E-mail address: rschultz@sas.upenn.edu (R.M. Schultz).generating novel transcripts that are not expressed in the
oocyte (Latham et al., 1991). Zygotic gene activation, as
determined by expression of plasmid-borne reporter genes,
transgenes, and endogenous genes (Aoki et al., 1997;
Bouniol et al., 1995; Christians et al., 1995; Kigami et al.,
2003; Matsumoto et al., 1994; Ram and Schultz, 1993),
initiates during the 1-cell stage and is clearly evident by the
2-cell stage (Latham et al., 1991; Schultz, 1993). Super-
imposed on genome activation is the development of a
chromatin-based transcriptionally repressive state
(Majumder and DePamphilis, 1995; Schultz, 2002) and a
more efficient use of TATA-less promoters (Davis and
Schultz, 2000; Majumder and DePamphilis, 1994) that
likely play a major role in establishing the appropriate
pattern of gene expression that is required for development.
The second developmental transition is compaction,
which occurs during the 8-cell stage (Fleming et al., 2001;
Johnson and Maro, 1986). Compaction, which is a Ca2+-
dependent process that requires E-cadherin (Hyafil et al.,
1981), is the first obvious morphological differentiation that
occurs during preimplantation development. Up to the 8-cell
stage, the blastomeres are quite distinct, but during compac-
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meres that are no longer clearly resolved. Accompanying this
morphological transition are pronounced biochemical tran-
sitions through which the blastomeres acquire characteristics
resembling somatic cells, reflected in such features as ion
transport, metabolism, cellular architecture, and gene expres-
sion pattern. Development of both gap junctions (Kidder and
Winterhager, 2001) and tight junctions (Fleming et al., 2001)
at the late 8-cell stage results in an epithelium that is essential
for continued and proper development.
Blastocyst formation is the next transition and occurs at
the 32- to 64-cell stage. Following compaction, subsequent
cleavage divisions allocate cells to the inside of the devel-
oping morula. These inner cells are allocated between the 8-
and 16-cell stages and then again between the 16- and 32-
cell stages (Pedersen, 1986). The inner cells of the morula
give rise to the inner cell mass (ICM) cells that then give
rise to the embryo proper, whereas the outer cells differen-
tiate into the trophectoderm (TE), which gives rise to
extraembryonic tissue. The TE is a fluid-transporting epi-
thelium that is responsible for forming the blastocoele
cavity, which is essential for continued development and
differentiation of the ICM (Biggers et al., 1988; Watson and
Barcroft, 2001). Blastocyst formation is the first time when
overt cellular differentiation occurs and is characterized by
differences in gene expression between the ICM and TE
cells. For example, expression of Oct4, a member of the
POU-domain family of transcription factors and essential to
maintain totipotency of the ICM cells (Nichols et al., 1998;
Pesce and Scholer, 2000), and Fgf4 (Niswander and Martin,
1992) become restricted to the ICM; while expression of
Bex1, the imprinted H19 gene, and Cdx2, a homolog of the
Drosophila homeotic caudal (Cad) gene, are restricted to the
TE in the preimplantation embryo (Beck et al., 1995;
Doherty et al., 2000; Williams et al., 2002).
To date, quantitative analysis of high-resolution, two-
dimensional protein gels (Latham et al., 1991), mRNA
differential display (Ma et al., 2001), and analysis of
expressed sequence tags (EST) derived from libraries of
various preimplantation stages (Ko et al., 2000; Sharov et
al., 2003) have been used to assess the global changes in
gene expression that occur during preimplantation develop-
ment. Although these approaches have shed some light on
the molecular basis underlying preimplantation develop-
ment, each has major limitations. Microarray techniques
provide a powerful approach to study global patterns of
gene expression. The ability to amplify the small amounts of
mRNA present in preimplantation mouse embryos, which
can only be isolated in limited numbers, makes it feasible to
generate enough material for microarray analysis.
Transcript profiling provides a measure of RNA abun-
dance, which can be affected not only by levels of transcription
but also by RNA processing and degradation. Moreover, not
all transcripts are translated and RNA abundance may not
correspond to protein levels, nor does RNA provide informa-
tion about protein modification, activity, or location. Theseimportant processes are not the focus of this study; instead
RNA expression is used as an initial indicator of the overall
activities of the genome during early mouse development.
Using Affymetrix oligonucleotide arrays containing
>39,000 transcripts and variants, together with a T7-based
linear double amplification method, we report here changes
in the global patterns of gene expression that occur during
preimplantation development in the mouse by analyzing
the gene expression profile in oocytes, 1-cell, 2-cell, and 8-
cell embryos, and blastocysts. While this work was being
prepared for publication, two studies appeared that used
microarrays to assess global patterns of gene expression
during preimplantation development (Hamatani et al.,
2004; Wang et al., 2004).Materials and methods
Collection of preimplantation mouse embryos
Mouse CF-1  B6D2F1/J embryos were isolated from
superovulated mice as previously described (Zeng and
Schultz, 2003). Oocytes were collected 46–48 h after
PMSG injection, and the following stages collected during
the indicated time period after hCG administration: 1-cell
(18–20 h), 2-cell (44–46 h), 8-cell (68–70 h), and blasto-
cyst (96–98 h). Four equal pools of embryos from each
stage were independently collected from separate sets of
fertilized mice, and a range of 80–430 embryos per pool
was collected to make the amount of total RNA recovered
approximately equivalent among all stages.
cDNA preparation for microarray analysis
Embryo pools were transferred to 150 Al of Trizol
(Invitrogen) containing 20 Ag of glycogen and stored at
80jC. When all replicates were collected, total RNA was
extracted according to the manufacturer’s instructions for
small sample preparation. Samples were submitted to the
Penn Microarray Facility for target preparation and Gene-
Chip hybridization. RNA mass and size distribution were
determined using the Agilent Bioanalyzer with RNA 6000
Nano LabChips; total RNA yield was 82–113 ng per
replicate pool. This total RNA was used for linear, two-
round amplification by in vitro transcription (Affymetrix
Small Sample Prep Technical Bulletin, www.affymetrix.
com). cRNA yield after the first amplification was 2.0–
10.8 Ag, and 0.5 Ag of each replicate was used as input
template for the second amplification. Final yield of bio-
tinylated cRNAwas 62–119 Ag, of which 15 Ag per replicate
was fragmented and hybridized to Affymetrix GeneChips.
cRNA samples were serially hybridized to MG_U74Av2,
MOE430A, and MOE430B GeneChips, then washed and
stained on fluidics stations and scanned at 3 Am resolution
according to the manufacturer’s instructions (GeneChip
Analysis Technical Manual, http://www.affymetrix.com).
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Microarray Analysis Suite 5.0 (MAS, Affymetrix) was
used to quantify microarray signals with default analysis
parameters and global scaling to target mean = 150. Quality
control parameters for all samples were within the following
ranges: scale factor 0.7–3.5 and background 44–83 for
U74Av2 and MOE430A; percent genes detected 31–49%
on U74Av2 or MOE430A and 16–23% on MOE430B; actin
3V/5V signal ratio 0.5–6.0, and GAPDH 3V/5V signal ratio
0.8–8.7 for all GeneChips. GeneChip tabular data are avail-
able at the Gene Expression Omnibus repository,
www.ncbi.nlm.nih.gov/geo. The MAS metrics output was
loaded into GeneSpring v6 (Silicon Genetics) with per-chip
normalization to the 50th percentile and per-gene normaliza-
tion to the median. A filtered list was created of all genes
detected (MAS ‘‘P’’ call) in at least three of four replicates of
at least one embryo stage. K-means hierarchical clustering
using this gene list correctly grouped all replicates as most
related by embryo stage, so the filtered list was used to search
for transcripts showing abundance differences. (Note: all
analyses described below were performed using Affymetrix
probe set lists, some of which were converted to Unigene
accession numbers as noted in the text and figure legends to
illustrate gene expression with reduced redundancy.)
Three independent analyses were then applied to identify
genes with statistically significant differences in any of the
stages tested. The GeneSpring pairwise comparison (Welch t
test with ANOVA, P = 0.05, Benjamini and Hochberg
multiple testing correction) was conducted between all
possible stage pairs. The GeneSpring multiclass analysis
(Welch t test with Welch ANOVA, P = 0.05, Benjamini
and Hochberg multiple testing correction) was applied to the
entire sample using the filtered gene list described above. A
one-way ANOVA for microarrays (lgsun.grc.nia.nih.gov/
ANOVA/index.html, default parameters except FDR <
0.05) was also conducted. A nonredundant list was compiled
containing candidate genes called significantly different in at
least one analysis. Expression profiles for all genes on the
candidate list were plotted in GeneSpring across all stages to
conduct pattern searches by the following strategies.
The GeneSpring ‘‘filter on fold change’’ and ‘‘draw gene’’
tools were applied to the nonredundant differentially
expressed gene list (Affymetrix probe sets) to locate genes
with expression profiles closely resembling various simple,
hypothetical patterns such as sustained increase or decrease.
Annotation-directed searches were performed to query genes
previously known to be involved in early developmental
processes. Transient change filters were applied to identify
genes increased by at least 1.4-fold in a single stage com-
pared to expression in all other stages. Similar fold-change
filters were used to find increases or decreases spanning more
than two consecutive stages. The pattern searches based on
fold-change filters generated subset lists of candidate genes,
which were then imported to EASE (version 2.0) to test for
overrepresentation of annotation classes (Hosack et al.,
F. Zeng et al. / Developmen2003). EASE analyses with Bonferroni multiplicity correc-
tion tested each subset list against the population of all genes
detected, and an EASE score was calculated for likelihood of
overrepresentation in the Gene Ontology Consortium anno-
tation categories GO biological process, GO cell component,
and GO molecular function, as well as KEGG pathway and
SwissProt keyword. GeneSpring ‘‘genomes’’ were built for
each of these annotation categories so that EASE scores from
all subset lists could be visualized in parallel across all
embryo stages. EASE analysis was also conducted for genes
expressed at each developmental stage.
Real-time RT-PCR analysis
In vivo-developed 1- and 2-cell embryos were collected
as described above and total RNA was isolated from 100
embryos at each stage. Two embryo equivalents of template
RNA were used for each real-time RT-PCR assay according
to manufacturer’s protocol using ABI Prism Sequence
Detection System 7000. To confirm the ability of this
microarray analysis to resolve small differences in expres-
sion level, six genes that showed a statistically significant
40–100% increase in expression between the 1- and 2-cell
stages were selected. The corresponding ABI TaqMan
Assay-on-Demand probe/pr imer sets used were
Mm00520817_m1 (LOC217716), Mm00485509_m1
( R a d 5 1 a p 1 ) , M m 0 0 4 5 7 0 4 6 _ m 1 ( T b p l 1 ) ,
Mm00494300_m1 (Zfp103), Mm00432498_m1 (Chkl),
Mm00442360_m1 (Ceacam1), and Mm00501974_s1 (His-
st2h2aa1). Three replicates were used for each real-time
PCR reaction; a minus RT and a minus template served as
controls. Quantification was normalized to the endogenous
histone H2Awithin the log-linear phase of the amplification
curve obtained for each probe/primer using the comparative
CT method (ABI PRISM 7700 Sequence Detection System,
user bulletin #2).Results and discussion
Hierarchical cluster analysis
Oocytes and embryos from four preimplantation stages
(1-cell, 2-cell, 8-cell, and blastocyst) were used for expres-
sion profiling to encompass the three aforementioned major
transitions that govern preimplantation development, that is,
maternal-to-zygotic transition (MZT), compaction, and blas-
tocyst formation. We elected to analyze embryos that
developed in vivo, rather than in vitro, to avoid the effect
of embryo culture on gene expression (Doherty et al., 2000;
Ho et al., 1994).
An unsupervised hierarchical clustering using either all
the genes on MOE430 or U74Av2 chips, or the nonredun-
dant list of genes that are expressed in the preimplantation
mouse embryo (Table 1), independently clustered correctly
all replicates by their appropriate developmental stage (Fig.
Table 1
Distribution of genes detected in the five preimplantation stages
Stage Genes
detected
Genes differentially
expressed
Oocyte 9909 9414
1-Cell 8793 8413
2-Cell 9951 9514
8-Cell 8312 7957
Blastocyst 10,242 9776
Total (nonredundant) 14,119 13,378
The number of Unigene accessions derived from genes detected (Affymetrix
‘‘P’’ call in at least 3 of 4 replicates) on the MOE430A and B GeneChips in
each stage, as well as the total number of non-redundant genes detected from
all five stages, are listed in the left column. One-way ANOVA and
GeneSpring ANOVA/Welch t-test (false discovery rate = 0.05) were then
used to identify genes showing a statistically significant expression
difference when compared to any other stage, and the number of non-
redundant genes resulting from this analysis is listed in the right column.
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cates. Furthermore, with the exception of a few genes, most
of the genes behaved similarly across the four replicates for
each developmental stage. The wider range of expression
among replicates for some genes may reflect the asynchrony
of embryo development in vivo.
The clustering dendogram (Fig. 1) reveals that the oocyte
and 1-cell, and 8-cell and blastocyst, are subgrouped togeth-
er. In contrast, the 2-cell is separated from the other stages,
forming an intermediate node between the oocyte/1-cell and
8-cell/blastocyst. The separation of the 2-cell embryo from
the other stages is consistent with previous results indicating
that the major reprogramming of gene expression occurs
during the 2-cell stage and is linked with the major period of
genome activation (Latham et al., 1991). This clearly sepa-
rates the 2-cell embryo from the 1-cell. The other burst of
reprogramming that occurs during the 4- to 8-cell stages (Van
Blerkom and Brockway, 1975) likely further distances the 8-
cell embryo from the 2-cell embryo. The dramatic reprog-
ramming in gene expression during the 2-cell stage, as
detected by hierarchical clustering analysis, was also
reported in the two recent microarray studies (Hamatani et
al., 2004; Wang et al., 2004). The changes in gene expression
that precede compaction, and recognized some 30 years ago
(Van Blerkom and Brockway, 1975), were likewise observed
in those studies (Hamatani et al., 2004; Wang et al., 2004).
The clustering of oocyte and 1-cell embryo transcript
profiles was anticipated. Although many changes in the
pattern of protein synthesis are observed following fertil-
ization, the majority of these are due to recruitment of
maternal mRNAs or posttranslational modifications of exist-
ing proteins (Van Blerkom, 1981). In addition, few newly
synthesized transcripts have been identified in the 1-cell
embryo (Kigami et al., 2003) that is now recognized as
being transcriptionally active (Aoki et al., 1997; Bouniol et
al., 1995). Last, although degradation of maternal mRNA
initiates during oocyte maturation, destruction of these
mRNAs is typically not complete until the late 2-cell stage.
Thus, most of the transcripts present in the 1-cell embryo arematernally derived. Following compaction, the patterns of
protein synthesis of 8-cell embryos and blastocysts are very
similar as assessed by 1D (Van Blerkom and Brockway,
1975) and high-resolution 2D gels (Latham, personnel
communication). The clustering of the 8-cell and blastocyst
stages was anticipated because the 8-cell embryos used in
our analyses were typically approximately 60% compacted
and 40% uncompacted. In toto, the concordance of the
hierarchical cluster analysis with previous results collected
by totally independent methods lends confidence to the
reliability of conclusions drawn from our transcript profiling
of preimplantation mouse embryos.
Derivation of nonredundant gene expression lists
All genes detected (Affymetrix ‘‘P’’ call) on MOE430A
and B GeneChips that were present in at least three of four
replicates of each stage were used to construct a nonredun-
dant list of genes expressed in the oocyte and preimplanta-
tion stages (Table 1). The resulting list of 18,108 Affymetrix
probe sets, corresponding to 14,119 Unigene annotations,
was used for three independent ANOVA analyses to identify
genes with statistically significant differences in RNA
expression in any of the stages tested as described under
Material and methods. A second nonredundant list was
compiled containing all of the candidate genes from all
the ANOVA tests and identified genes that are significantly
different in at least one stage. This list contains 13,378
(17,193 probe sets) of the 14,119 detected genes. As the
ANOVA analyses will eliminate genes that are not statisti-
cally different in any of the pairwise comparisons or across
all stages, as well as genes with poor quality signals from
the GeneChip hybridization and MAS procedures, we find
that approximately 95% of the detected genes have altered
expression levels in one or more stages during preimplan-
tation development. In particular, as shown in Table 1, the
majority of the genes that are present in each stage are also
statistically significantly different. The decrease in the
number of genes in the 1-cell embryo relative to the oocyte
and the subsequent increase by the 2-cell stage reflects
degradation of maternal mRNAs that initiates during oocyte
maturation and the expression of zygotic transcripts con-
comitant with genome activation during the 2-cell stage as
described above. Similar overall results were obtained using
the U74Av2 microarray (data not shown).
The Penn Microarray Facility has processed a wide
variety of mouse tissues and cell types on MOE430 Gene-
Chips. The number of genes detected generally ranges from
30% to 50% of all genes on the MOE430A or U74Av2, and
10–15% on the MOE430B. The proportion detected (see
Materials and methods) in this study is within the normal
range for the MOE430A GeneChip (or for U74Av2) and
somewhat higher than usual for the MOE430B GeneChip.
The MOE430B probe sets assay genes that tend to be
expressed at lower levels and are represented by EST
sequences only or do not occur frequently in sequence
Fig. 1. Hierarchical clustering analysis of all samples from different developmental stages. Unsupervised clustering in GeneSpring was used to analyze
similarities among replicate samples across all stages tested. Replicate sample numbers are indicated at the bottom of the figure. Stage abbreviations in the tree
diagram are as indicated under Materials and methods. Colors correspond to relative RNA abundance for the detected genes (Affymetrix ‘‘Present’’ call in at
least one embryo stage, 18,108 probe sets), each of which is represented by one horizontal bar.
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embryo stages tested may express a number of these rarer
and less well-characterized genes.
Our analysis strategy focused first on consistently
detected transcripts, then measured the likelihood of differ-
ence given observed levels of variance, and finally consid-
ered the magnitude of change. Furthermore, the use of four
biological replicates provided sufficient statistical power
and confidence levels to detect a 40% change of RNA
abundance for a significant portion of the detected genes
(Table 2, and see below). That such modest changes in the
expression of a gene can result in profound differences is
gaining more appreciation. For example, the transcriptionfactor OCT4 is critical in maintaining pluripotency of stem
cells (Pesce and Scholer, 2000). Oct4 is expressed initially
in all blastomeres, but in the late blastocyst it is expressed in
the inner cell mass (ICM) cells, down-regulated in trophec-
toderm, but up-regulated in primitive endoderm (Palmieri et
al., 1994). Eventually, Oct4 expression is confined exclu-
sively to the developing germ cells (Yeom et al., 1996).
Experimentally, manipulating levels of Oct4 expression by
approximately 50% implicated Oct4 as a developmental
switch in regulating the fate of ES cells, for example, higher
levels lead to differentiation into primitive endoderm and
mesoderm, intermediate levels lead to pluripotent stem cells,
and reduced levels result in trophectoderm (Niwa et al.,
Fig. 2. Validation of expression profiles of previously characterized genes
of interest. (A) Shown are average microarray expression levels of selected
genes. These profiles match previously determined individual patterns. (B)
Statistically significant differences between adjacent stages are indicated by
an asterisk.
Table 2
Number of genes with altered expression levels by stage
Stage Fold change
>1.4 >2 >5
Oocyte 1370 572 46
1-Cell 1877 313 3
2-Cell 911 427 91
8-Cell 1131 368 22
Blastocyst 2739 1401 306
The table displays the number of Affymetrix probe sets on MOE430 arrays
showing a higher RNA abundance in the indicated stage compared to any
other stage. Genes are categorized by magnitude of difference between
expression levels in the indicated stage and the next highest level among all
other stages. These data were generated from the nonredundant list of
significantly different genes throughout preimplantation development.
F. Zeng et al. / Developmental Bi4882000). Thus, small changes in expression of a critical
transcription factor or a gene that acts in the early steps of
a signal transduction pathway could function as a molecular
switch that would lead to widespread and dramatic changes
in gene expression.
Validation of expression patterns
Before analyzing the transcript profiles, we first validated
expression patterns observed using the GeneChips with
those of several genes for which the temporal pattern of
expression has been previously determined by other meth-
ods, for example, RT-PCR. For all the genes queried against
the data set, temporal patterns of expression were observed
to be similar to those reported. Some representative genes
that show interesting patterns of expression are shown in
Fig. 2. For example, the maternally expressed Mos proto-
oncogene showed a dramatic decrease in expression from
the oocyte to blastocyst stage; the murine endogenous
retrovirus-like gene (MuERV-L) (Wang et al., 2001) dis-
played a transient increase in expression during the 2-cell
stage; the Na+/K+-ATPase, h1 subunit (Atp1b1) (Gardiner et
al., 1990) and the imprinted H19 gene (Doherty et al., 2000)
increased between the 8-cell and blastocyst stage; maternal
G protein alpha inhibiting 3 (Gnai3) (Williams et al., 1996)
was degraded and then replaced by zygotic transcripts; and
expression of the inactive X specific transcript (Xist) was
first detected in 2-cell embryos and then accumulated and
reached a plateau by the morula stage (Hartshorn et al.,
2002).
To confirm that the microarray analysis could detect a
small-fold change in expression, six genes that displayed
such a small and statistically significant increase between
the 1- and 2-cell stages were arbitrarily selected for real-
time PCR analysis and in each case an increase was
observed between these two developmental stages (Fig.
3). These two independent confirmations shown in Figs. 2
and 3 strongly suggest that the expression profiles obtained
from the GeneChip analysis accurately reflect qualitative
changes in gene expression that occur during preimplan-
tation development.EASE analysis of gene expression
The mouse genome is estimated to contain approximately
30,000 protein-coding genes, and their biological process
classification by GO annotation indicates a distribution of
functional classes very similar to that found in the human
genome. The 10 most common processes, in descending
order by percentage of all genes, were reported as follows:
protein metabolism, other metabolic processes, RNA me-
tabolism, DNA metabolism, transport, cell cycle or prolif-
eration, cell organization or biogenesis, signal transduction,
cell adhesion, and developmental processes (Waterston et
al., 2002). This distribution is mirrored in the GO annota-
tions of genes assayed on the Affymetrix mouse GeneChip
microarrays used in this study, as well as in the distribution
of all genes detected in at least one embryo stage. Listing
detected genes by individual stage, however, suggests that a
number of biological processes are overrepresented com-
pared to the overall distribution described above. These lists
were analyzed to describe biological process themes that
may be of functional importance in individual embryo
stages, using Expression Analysis Systematic Explorer
(EASE) (Hosack et al., 2003).
EASE is a recently developed program that facilitates the
biological interpretation of gene lists derived from results of a
microarray analysis. It provides statistical methods (reported
as an EASE score) for discovering biological themes within
gene lists using previously published annotation databases to
generate gene annotation tables. In particular, the overrepre-
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Fig. 3. Real-time RT-PCR confirmation of selected genes. Shown are real-time RT-PCR results of six arbitrarily selected genes that display a 1.4- to 2-fold
increase in expression between the 1- and 2-cell stages according to microarray analysis; equal numbers of 1- and 2-cell embryos were used. Three replicates
were used for each real-time PCR reaction from each stage. In each case, an increased expression was observed in 2-cell embryos compared to 1-cell embryos
after normalizing to histone H2A, which served as an internal control (data not shown).
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way of identifying and converting the results of functional
genomics studies from ‘‘genes to themes’’ (Hosack et al.,
2003). Overrepresentation does not refer to abundance of
gene expression but rather describes a class of genes that have
similar functions, for example, transcription factors, regard-
less of their expression level, that appear more often in a list
of interest than would normally be predicted by their distri-
bution among all genes assayed. The method incorporates
jackknife iterative resampling of Fisher exact probabilities,
with Bonferroni multiple testing correction, to generate an
EASE score that indicates increasing confidence in overrep-
resentation as the score decreases toward zero. The overrep-
resented set thus describes a ‘‘biological theme’’ of categories
enriched in a particular condition or stage compared to a
background population.
We applied EASE analysis to find gene categories that
are overrepresented in a particular stage compared to the
population of all genes that are expressed in preimplantation
mouse embryos from the MOE430 chips, using GO biolog-
ical process and other annotation categories (see Material
and methods). Listed in Table 3 are the overrepresented GO
biological processes that have EASE scores of 0.05 or lower
in any stage and the corresponding EASE scores across thefive stages. (See Supplemental Table S1 for a complete list
of GO biological processes that passed EASE <0.05 filter).
The robustness of the EASE analysis is highlighted by it
identifying overrepresented GO biological process categories
that are consistent with previous findings (Table 3). For
example, the absolute rate of protein synthesis increases
during preimplantation development from the oocyte to 8-
cell stage (Schultz et al., 1979), and EASE analysis identified
overrepresentation of genes in protein synthesis. Moreover,
overrepresentation of genes involved in ribosome biogenesis
and assembly processes (LaMarca and Wassarman, 1979),
such as rRNA processing, was identified by EASE analysis.
Lastly, the assembly of a functional nucleolus (Zatsepina et
al., 2003) following fertilization in the preimplantation em-
bryo is consistent with the overrepresentation of genes related
to transcription from Pol I promoters. These changes in genes
implicated in rRNA synthesis and ribosome biogenesis may
underlie the global increase in the rate of protein synthesis.
The increase in GO biological processes classified as
tricarboxylic acid cycle and oxidative phosphorylation at
the 8-cell stage and carbohydrate metabolism at the blastocyst
stage are consistent with a metabolic switch that occurs
around the 8-cell stage. Before compaction, pyruvate is the
main energy source (Gardner, 1998), mitochondrial cristae
Table 3
Selected biological processes overrepresented in each developmental stage
GO biological process Overrepresentation (EASE score)
Oo 1C 2C 8C BL
Protein biosynthesis 6.3E06 2.4E04 6.0E04 5.4E12 1.2E14
Ribosome biogenesis and assembly 1.8E04 3.4E02 9.1E04 1.6E10 1.3E06
Transcription from Pol I promoter 4.0E02 * 2.4E02 2.7E04 *
Carbohydrate metabolism * * * * 2.6E02
Tricarboxylic acid cycle * * * 4.8E03 4.2E02
Oxidative phosphorylation 3.2E02 * * 2.0E02 4.2E02
Chromatin assembly or disassembly * 1.7E02 1.3E02 * *
DNA repair 5.9E03 * * * *
Response to DNA damage stimulus 9.8E04 * * * *
The EASE analysis tool was used to calculate likelihood of overrepresentation for annotation categories associated with each group of genes detected in at least
three of four replicates of a stage. Lists of genes detected in each stage were compared to the population of all genes detected in any stage (the lists of genes
detected from Table 1). Biological process categories with an EASE score <0.05 were grouped into functional classes. A complete list of GO biological
processes from each stage can be found in Supplemental Table S1.
* Functional classes with an EASE score >0.05 in that particular stage.
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are high (Ginsberg and Hillman, 1975), and oxygen con-
sumption is low and largely cyanide insensitive (30%)
(Trimarchi et al., 2000), which taken together indicate a
low level of oxidative phosphorylation. By the blastocyst
stage, there is an increase in oxidative phosphorylation as
evidenced by glucose being the main energy source (Gardner,
1998), mitochondrial cristae are of normal morphology, that
is, traverse (Calarco and Brown, 1969), expression of genes
critical for oxidative phosphorylation is increased (Piko´ and
Taylor, 1987; Taylor and Piko, 1995), ATP/ADP ratios are
markedly reduced (Ginsberg andHillman, 1975), and oxygen
consumption is dramatically increased and largely cyanide
sensitive (70%) (Trimarchi et al., 2000). The increase in ATP
production is likely critical for supporting increased anabolic
pathways such as protein and RNA biosynthesis and the ion-
transporting activities required for blastocyst formation.
The enrichment of genes functioning in chromatin as-
sembly or disassembly in the 1- and 2-cell stages is
consistent with the temporally regulated changes in chro-
matin structure that commence in the 1-cell embryo and
progress through the 2-cell stage. Remodeling of the pater-
nal genome entails a protamine-histone exchange, active
DNA demethylation (Oswald et al., 2000; Santos et al.,
2002), and preferential accumulation of hyperacetylated
histones (Adenot et al., 1997). Collectively, these changes
may provide a window of opportunity for transcription
factors to gain access to their cis-cognate DNA binding
sequences and account for the higher level of transcription
that occurs in the male pronucleus when compared to the
female pronucleus (Aoki et al., 1997; Bouniol et al., 1995).
During the 2-cell stage, a chromatin-mediated transcription-
ally repressive state develops (Majumder and DePamphilis,
1995) that can be relieved by inducing histone acetylation or
inhibiting the second round of DNA replication (Davis et
al., 1996; Ma et al., 2001; Majumder and DePamphilis,
1995), which could provide another opportunity to remodel
the zygotic genome.For the majority of these processes, the EASE values are
highest at the 8-cell stage, when the first epithelium forms
and the blastomeres assume more somatic cell-like proper-
ties. These changes may highlight this transition and serve
to prepare the embryo for differentiation into trophectoder-
mal and ICM cells.
EASE analysis revealed certain processes that were not
suggested from previous studies. For example, response to
DNA damage and DNA repair genes is overrepresented in the
oocyte when compared to 1-cell through blastocyst stages.
This overrepresentation may reflect the oocyte’s response to
selective pressures to insure genomic integrity. Following
birth, the female inherits her full complement of oocytes,
which are nondividing cells. The oocytes remain arrested in
the first meiotic prophase before their recruitment into a
growing follicle, and this period before oocyte growth and
development can last for years, for example, >40 years in
humans. Thus, genes critical to maintain genomic integrity of
the female germline, that is, genes that compose the DNA
repair machinery and involved in responding to DNA dam-
age, may become overrepresented. Two examples are Rad51,
a component of the postreplication, homologous DNA mis-
match repair machinery (Sung et al., 2003), and Xrcc5
(Ku80), which is critical for the nonhomologous end joining
DNA repair pathway (Featherstone and Jackson, 1999).
EASE analysis of genes with interesting expression profiles
To examine further possible roles of genes whose ex-
pression profile is linked with specific developmental tran-
sitions (see Introduction), the nonredundant, differentially
expressed gene list (Table 1) was used to group genes
according to their temporal expression patterns. These gene
lists were then subjected to EASE analysis to identify
functional categories that are overrepresented for a particu-
lar expression pattern. Our discussion focuses on six ex-
pression profiles, namely, maternal, maternal-to-zygotic, 1-
cell transient, 2-cell transient, 8-cell transient, and blastocyst
Fig. 4. Expression profiles of six major expression patterns during preimplantation development. The number of Unigenes presented in these patterns
(designated maternal, maternal-zygotic, 1C transient, 2C transient, 8C transient, and blastocyst) is indicated in parentheses. Colors correspond to relative RNA
abundance (as in Fig. 1) at the stage most characteristic of that particular pattern. For example, expression levels at the oocyte stage set each gene’s profile color
used for comparison to other stages in the ‘‘maternal’’ expression pattern; the 1C stage was similarly used as the relative abundance reference for the ‘‘1C
transient’’ pattern.
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complete list of genes that show each expression profile,
Supplemental Table S3 for lists of genes that are represented
in each functional category in Table 4, and Supplemental
Table S4 for complete lists of GO categories, including
biological process and molecular function, as well as the
Swissprot keyword and KEGG pathway search that passed
EASE score <0.05 filter.)
Oocyte maturation initiates the destruction of many ma-
ternal RNAs and this destruction continues following fertil-
ization and through the 2-cell stage, resulting in a >90%
decrease in mass of these transcripts (Schultz, 2002). One
class of transcripts continues to be degraded following
genome activation at the 2-cell stage (i.e., maternal) while
another class is replaced by zygotic transcripts (i.e., maternal-
zygotic). Because the ‘‘maternal-zygotic’’ pattern represents
replacingmaternal transcripts with zygotic transcripts that are
common to the oocyte and early embryo, for example, actin, it
is not surprising that gene categories overrepresented in this
group consist largely of basic cellular functions. In particular,
out of the 632 genes in this group that have GO biological
process annotation, 63% function in metabolism, such as
electron transport and oxidative phosphorylation, coenzyme
metabolism, protein metabolism, lipid metabolism, or nucle-
otide metabolism including ATP synthesis.
Genes with ‘‘maternal’’ patterns include oocyte-specific
genes such as Mos and Zp3 but also include many non-oocyte-specific transcripts. Of interest is that the most
prominent overrepresented category (approximately 27%
of the 297 genes with GO annotation for biological process)
is involved in cell communication (including the subcate-
gory of signal transduction, half of which are related to cell
surface receptor-linked signal transduction and cell adhe-
sion). The oocyte and companion follicle cells communicate
bidirectionally during folliculogenesis by both gap junction-
mediated and paracrine mechanisms (Matzuk et al., 2002).
The outcome is a preovulatory antral follicle that harbors a
highly differentiated oocyte; oocytes, which are the only
cells in the female that can undergo meiosis, express oocyte-
specific genes, and only oocyte cytoplasm can reprogram a
nucleus to support development to term. Following fertil-
ization, however, oocytes are transformed to blastomeres
that remain totipotent until the 8-cell stage (Handyside,
1978). The embryo develops in an environment rich in
extracellular signals and the decrease in representation of
genes involved in cell communication may reflect a require-
ment to insulate the embryo from these signals so that the
blastomeres may remain totipotent.
We next examined three transient expression patterns
designated 1-cell, 2-cell, and 8-cell; transiently expressed
genes are defined as genes whose expression is at least 40%
higher in one stage compared to the other four stages. The
existence of transient expression during the 2-cell stage is
well documented from previous studies using quantitative
Table 4
Selected biological processes overrepresented in major expression patterns
Gene pattern Overrepresented categories of biological processes EASE score No. of
genes
Supplemental
Table S3
Maternal Cell communication 4.69E05 81 A1
A. Signal transduction 4.07E03 61 A2
Cell surface receptor linked signal transduction 3.71E03 30 A3
B. Cell adhesion 6.91E03 19 A4
Maternal-zygotic Metabolism 1.14E03 400 B1
A. Electron transport or oxidative phosphorylation 3.09E04 48 B2
B. Coenzyme metabolism 1.12E05 25 B3
C. Nucleotide metabolism—nucleoside triphosphate metabolism 7.89E03 10 B4
D. Lipid metabolism 3.56E03 16 B5
E. Protein metabolism 1.64E02 167 B6
Transient 1-Cell Protein metabolism—protein modification 3.17E05 114 C1
Protein amino acid phosphorylation 2.91E03 60 C2
Cell proliferation—cell cycle 9.56E04 78 C3
Mitotic cell cycle 3.40E02 36 C4
Transcription—regulation of transcription 2.32E02 131 C5
DNA metabolism 4.23E02 52 C6
Transient 2-Cell Transcription 2.54E04 86 D1
Regulation of transcription, DNA dependent 9.46E03 70 D2
RNA metabolism—RNA processing 2.22E03 23 D3
mRNA processing 7.79E03 13 D4
Metabolism 2.66E03 264 D5
Phosphate metabolism—protein amino acid dephosphorylation 3.40E02 10 D6
Cell cycle—regulation of cell cycle 2.37E02 23 D7
Transient 8-Cell Metabolism
A. Biosynthesis 7.63E04 70 E1
1. Protein biosynthesis 1.18E02 40 E2
2. Phospholipid biosynthesis 1.67E02 6 E3
B. Amine metabolism or amino acid metabolism 8.37E03 18 E4
Ribosome biogenesis 6.05E03 12 E5
Transport—protein targeting 2.63E02 19 E6
Blastocyst Metabolism 1.23E02 32 F
Gene patterns listed in the table are as shown in Fig. 4. After EASE analysis, characteristic biological processes are listed for annotated genes in that particular
pattern with an EASE score less than 0.05. The number of genes in each pattern or category is shown next to the EASE score. See Supplemental Table S2 for a
complete list of genes for each gene expression pattern. Details for genes listed in column 4 can be found in Supplemental Table S3 (A1–F). See Supplemental
Table S4 for a complete list of functional categories that are overrepresented.
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1991), mRNA differential display (Ma et al., 2001), and RT-
PCR (e.g., Davis et al., 1996; Latham et al., 1995), but the
number of genes identified was quite limited. We identified
1587 (1879), 809 (911), and 950 (1132) Unigenes (Affyme-
trix probe sets) transiently expressed in 1-cell, 2-cell, and 8-
cell stages, respectively (Fig. 4 and Supplemental Table S2
for a complete list of genes).
The large number of transcripts displaying a transient
increase during the 1-cell stage was unanticipated. This
subset includes 18% of all genes (8793 Unigenes)
expressed in the 1-cell embryo (Table 1). Note that one
highly overrepresented gene category is ‘‘regulation of
transcription’’ that consists of 15.5% of all genes annotated
(131 of 848) in the 1-cell transient list. Even though the 1-
cell embryo is transcriptionally competent (Aoki et al.,
1997; Bouniol et al., 1995), the majority of these transcripts
are likely maternal mRNAs recruited following egg activa-
tion—mRNA recruitment entails polyadenylation (e.g., Oh
et al., 2000) that would lead to more efficient oligo-dT
priming and hence an apparent increase in transcriptabundance—because a-amanitin inhibited the up-regulation
of only 1 out of 47 up-regulated 1-cell transcripts (Hama-
tani et al., 2004). Recruitment of maternal mRNAs appears
coupled to genome activation because inhibiting polyade-
nylation inhibits transcription in 1-cell embryos (Aoki et
al., 2003). The other gene categories that are overrepre-
sented include protein modification (13.4%), cell cycle
(9.2%), and DNA metabolism (6.1%). Many of the changes
in the pattern of protein synthesis that occur following egg
activation are due to protein phosphorylation, and in
particular, protein phosphorylation catalyzed by the
cAMP-dependent protein kinase, PKA, appears necessary
for genome activation (Latham et al., 1992; Poueymirou
and Schultz, 1989). These previous findings agree with the
EASE analysis that revealed a significant number of genes
function in protein modification, half of which are involved
in protein phosphorylation, including PKA. In addition,
after fertilization, the newly formed 1-cell embryo must
initiate DNA replication for the first time following a long
hiatus; the last round of DNA replication occurred when
the oogonia underwent DNA replication and entered the
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not surprising that genes functioning in cell cycle (9.2%),
especially in the mitotic cell cycle (50% of this group), as
well as DNA metabolism (6.1%) would be overrepresented
(e.g., DNA replication genes Recc1, Blm, Nfib, Pcna, and
Orc6l, and DNA methylation genes Dnmt2 and Dnmt3a).
Although the 1-cell embryo is transcriptionally active,
the major phase of genome activation occurs during the 2-
cell stage (Schultz, 2002) and likely underlies the transfor-
mation of the differentiated oocyte into the totipotent
blastomeres; this reprogramming was evidenced from the
hierarchical cluster analysis described above. The class of
genes transiently expressed during genome activation has
been proposed to indicate that genome activation is global
and relatively promiscuous, and that a function of the
transcriptionally repressive state is to dictate the appropriate
profile of gene expression that is compatible with further
development (Ma et al., 2001). Thus, although genes with
strong promoters and/or enhancers would be preferentially
expressed, many other genes may be inappropriately, that
is, opportunistically expressed (especially at basal levels of
transcription) during this transition. An example is the
transient expression of MuERV-L during the 2-cell stage
(Ma et al., 2001; Wang et al., 2001). The formation of a
transcriptionally repressive state could preferentially de-
crease the expression of these genes but permit the contin-
ued expression of genes that are regulated by strong
promoters or enhancers. EASE analysis suggests that this
view is an oversimplification.
EASE analysis of the 411 GO biological process anno-
tated genes in the 2-cell transient list showed that 86 genes
(20.9%) are related to transcription. Also note that EASE
analysis at each developmental stage indicated an overrep-
resentation of genes involved in chromatin remodeling
during genome activation (Table 3). The majority of these
genes regulate DNA-dependent transcription (17.0%), 20%
of which are for transcription from Pol II promoters (exam-
ples include Gabpa, Dr1, Idb4, Crsp2, Klf9, Chd1, Zfp148,
and Taf9). Similarly, RNA metabolism in the form of RNA
processing (5.6%) is overrepresented. More than half of
these genes function in mRNA processing, including ASF,
Rbmx, Nssr, and Rngtt. These results suggest that a specific
subset of genes, that is, genes involved in transcription and
RNA metabolism, is transiently expressed and may be
critical to ‘‘kick-start’’ genome activation.
A smaller class of 23 genes (5.6%) functioning in
regulation of cell cycle is overrepresented in the 2-cell
transient as compared to the 1-cell transient group (9.2%).
Although similar in functional annotation, the individual
cell cycle genes from the 1- and 2-cell transient groups are
different. Six of the 23 cell cycle genes in the 2-cell
transient list function in the G1/S transition of mitotic cell
cycle. This may reflect the relatively short G1 phase in the
2-cell embryo (Bolton et al., 1984), which contrasts to the
lengthy G1 phase (approximately 10 h) in the 1-cell
embryo (Aoki and Schultz, 1999). Another overrepresentedgene category includes 10 genes implicated in protein
dephosphorylation in contrast to the overrepresentation of
genes involved in protein phosphorylation detected in the
1-cell transient group.
Genes overrepresented in the transient 8-cell groups (a
total of 457 genes annotated for GO biological process)
were involved in the biological processes of biosynthesis
(15.3%, 57.1% of which are for protein biosynthesis),
ribosome biogenesis (2.6%), and protein targeting (4.2%).
These changes may underlie the dramatic increase in
protein synthesis that follows compaction (Epstein and
Smith, 1973; Van Blerkom and Brockway, 1975) and the
transition from totipotent blastomeres to blastomeres of
restricted potential (Handyside, 1978) and more somatic
cell-like. Consistent with an increased demand for plasma
membrane biogenesis—there is an increase in surface area
due to cell division in the absence of net growth—is the
overrepresentation of genes in phospholipid biosynthesis.
Last, a relatively small set of genes (80) characterized the
‘‘blastocyst’’ expression profile, that is, genes first turned
on at the blastocyst stage or after the 8-cell stage. Only one
biological process, the generalized ‘‘metabolism’’ category
(76.2% out of the 42 annotated in this group), passed the
EASE score filter (V0.05) and could be considered as
overrepresented.
As mentioned in the Introduction, there are two very
recent published studies that used microarrays to assess
global patterns of gene expression during preimplantation
development (Hamatani et al., 2004; Wang et al., 2004).
The combination of these studies and the results described
here offer a comprehensive data set covering nearly all
mouse genes throughout embryogenesis. Wang et al. (2004)
utilized the Affymetrix U74Av2 GeneChip to profile many
developmental stages whereas Hamatani et al. (2004) used
the NIA 22K microarray, a printed oligomer array of genes
identified from mouse embryo cDNA libraries and thought
to be embryo specific or enriched. RNA profiles reported
here were initially assayed on the U74Av2 GeneChip, then
expanded to MOE430A and B GeneChips, with good
concordance between the two versions of Affymetrix
arrays. The MOE430 set provides greater gene coverage
than the U74Av2 array (2.8) and benefits from whole-
genome sequencing to reduce the number of redundant
probe sets and improve probe sequence quality. Preliminary
mapping of the overlap between the MOE430 set and the
NIA 22K platforms indicates that approximately 60% of the
NIA array is covered in the MOE430 set, and another
approximately 8100 transcripts are assayed only on the
NIA array. In addition, approximately 26,500 transcripts
are assayed only on the MOE430 chips, approximately
8400 of which are detected in the preimplantation mouse
embryo.
In summary, our large-scale microarray analysis for
transcript profiling during preimplantation mouse embryo
development appears reliable and has a high degree of
statistical confidence. The analysis confirmed previous
F. Zeng et al. / Developmental Biology 272 (2004) 483–496494conclusions drawn from analyses of a limited number of
genes, for example, a dramatic reprogramming of gene
expression occurs during the 2-cell, but also revealed
unanticipated insights that could not be deduced previously
from analysis of a limited number of genes. In addition,
these results validate this hypothesis-generating approach
by identifying genes involved in critical biological process-
es that will be the subject of the more traditional hypoth-
esis-driven approach.Acknowledgments
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